top of page
Back to Projects
Managing Obesity .jpg

Rheumatology Prescribing Practices

Rheumatology & Musculoskeletal
2024-03-05 – Present

Rheumatoid arthritis (RA) is the most prevalent inflammatory arthritis affecting an estimated 1.2% of Canadians aged 16 years and older. The economic burden of RA in Canada was estimated at $5.7 billion annually in 2011 and is rising due to an aging population.1 Sub-optimal care results in poor short- and long-term outcomes for people with RA including joint pain, stiffness, swelling and damage, and over time, also increases the risk for mood disorders, serious infections, joint replacement surgery, heart disease and stroke.  


RA is the most common condition managed by rheumatologists and understanding current individual and group practices will provide insights into ensuring best outpatient care for people with RA, decreasing the need for acute care services and reducing costs.


Drs. Steven Katz, Andrea Johnson and PLP Medical Director Dr. Oliver David are leading this project which aims to understand and improve how people with RA are receiving care in Alberta using administrative health data to engage rheumatologists and health system partners in facilitated sessions to reflect on the data and identify opportunities for improvement. Rheumatologists may consent to receive confidential, aggregate level reports on their practice.

Administrative data has been pulled and analyzed to create the cohort of patients with RA using a validated case definition.

 

Data analysis has been conducted that informs how people with RA are receiving care in Alberta including:

  • Demographics of people with RA

  • Health care utilization among people with RA including frequency of encounters

  • Dispensation of medications used for pharmacological management of RA

  • Timing and update of preventative vaccinations among people with RA

Report templates have been co-designed and report generation processes are being developed.

 

Twenty-one rheumatologists have consented to receive confidential, aggregate level reports on their practice and will be invited to participate in a facilitated audit and group feedback session in Fall 2026.


Engaging rheumatologists with their own clinical data will help improve care for patients with rheumatoid arthritis across Alberta.

 

1 Hazlewood, G. S., Pardo Pardo, J., Barnabe, C., Schieir, O., Barber, C. E. H., Proulx, L., Richards, D. P., Tugwell, P., Bansback, N., Akhavan, P., Bombardier, C., Bykerk, V., Jamal, S., Khraishi, M., Taylor-Gjevre, R., Thorne, J. C., Agarwal, A., & Pope, J. E. (2022). Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying antirheumatic drugs. The Journal of Rheumatology, 49(10), 1092–1099. https://doi.org/10.3899/jrheum.220209.

Related to this project
Project Events
Project Tools
bottom of page